0.6462  0.076 (13.37%)		05-13 13:31
Open: 0.56 High: 0.69 Volume: 2,146		Pre. Close: 0.57 Low: 0.56 Market Cap: 4(M)

Short term
Mid term
Targets	6-month :	1.01	1-year :	1.18
Resists	First :	0.87	Second :	1.01
Pivot price	0.52
Supports	First :	0.55	Second :	0.35
MAs	MA(5) :	0.57	MA(20) :	0.57
	MA(100) :	1.44	MA(250) :	4.45
MACD	MACD :	-0.1	Signal :	-0.2
%K %D	K(14,3) :	73.3	D(3) :	57.8
RSI	RSI(14): 53.5
52-week	High :	13.74	Low :	0.27

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RBOT ] has closed It is unclear right now based on current values. 67.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.65 - 0.65	0.65 - 0.66
Low:	0.54 - 0.55	0.55 - 0.55
Close:	0.57 - 0.57	0.57 - 0.57

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Wed, 13 May 2026
Robot surgeon runs for hours in complex hernia tests at Vicarious Surgical - Stock Titan

Thu, 30 Apr 2026
Vicarious Surgical (RBOT) faces going concern and NYSE delisting after Q1 loss - Stock Titan

Thu, 30 Apr 2026
Vicarious Surgical Inc. 1Q 2026: Net loss $(7.3M), EPS $(1.03) — 10-Q Summary - TradingView

Wed, 08 Apr 2026
Vicarious Surgical Shareholders Approve Reverse Stock Split Authorization - TipRanks

Mon, 30 Mar 2026
Vicarious Surgical completes testing milestone for surgical robot - MassDevice

Tue, 17 Mar 2026
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing - Orthopedics This Week

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: OTC
Sector: Healthcare
Industry: Medical - Devices
Shares Out	6 (M)
Shares Float	0 (M)
Held by Insiders	14.6 (%)
Held by Institutions	32.6 (%)
Shares Short	264 (K)
Shares Short P.Month	311 (K)

EPS	-6.62
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.37
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.11
PEG Ratio	0
Price to Book value	0.5
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.